Valuation Sanofi Nasdaq

Stocks

Market Closed - Nasdaq 01:30:00 29/10/2026 am IST			5-day change	1st Jan Change
42.24 ^USD	+0.84%		+3.10%	-12.84%

27/10	Fed, ECB, BoJ and Big Tech, the week that could turn markets around
26/10	A Week of Reckoning for Wall Street

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,11,194	1,12,665	1,12,549	1,16,968	1,00,655	90,466	-	-
Change	-	1.32%	-0.1%	3.93%	-13.95%	-10.12%	-	-
Enterprise Value (EV) ¹	1,21,177	1,19,102	1,20,342	1,25,740	1,11,663	1,01,804	98,471	95,805
Change	-	-1.71%	1.04%	4.49%	-11.2%	-8.83%	-3.27%	-2.71%
P/E	17.8x	16.7x	20.8x	20.4x	12.9x	12x	10.4x	8.94x
PBR	1.62x	1.5x	1.52x	1.51x	1.41x	1.23x	1.16x	1.09x
PEG	-	2.07x	-1.1x	3.14x	0.3x	-6.91x	0.7x	0.5x
Capitalization / Revenue	2.94x	2.62x	2.61x	2.85x	2.31x	1.9x	1.78x	1.69x
EV / Revenue	3.21x	2.77x	2.79x	3.06x	2.56x	2.14x	1.94x	1.79x
EV / EBITDA	9.95x	8.14x	8.44x	9.76x	8.22x	6.92x	6.21x	5.57x
EV / EBIT	11.3x	9.13x	9.5x	11.1x	9.19x	7.69x	7.1x	6.42x
EV / FCF	15x	14x	14.2x	21.1x	13.8x	12.5x	10.6x	9.29x
FCF Yield	6.68%	7.12%	7.04%	4.74%	7.24%	8.01%	9.41%	10.8%
Dividend per Share ²	3.33	3.56	3.76	3.92	4.12	4.266	4.51	4.815
Rate of return	3.76%	3.96%	4.19%	4.18%	4.98%	5.65%	5.97%	6.38%
EPS ²	4.97	5.37	4.31	4.59	6.4	6.289	7.263	8.445
Distribution rate	67%	66.3%	87.2%	85.4%	64.4%	67.8%	62.1%	57%
Net sales ¹	37,761	42,997	43,070	41,081	43,626	47,600	50,704	53,621
EBITDA ¹	12,183	14,627	14,259	12,889	13,583	14,718	15,868	17,207
EBIT ¹	10,714	13,040	12,670	11,343	12,149	13,241	13,877	14,925
Net income ¹	6,223	6,720	5,400	5,744	7,813	7,678	9,083	10,597
Net Debt ¹	9,983	6,437	7,793	8,772	11,008	11,337	8,005	5,339
Reference price ²	88.58	89.84	89.76	93.74	82.72	75.51	75.51	75.51
Nbr of stocks (in thousands)	12,55,293	12,54,060	12,53,891	12,47,793	12,16,810	11,98,069	-	-
Announcement Date	04/02/22	03/02/23	01/02/24	30/01/25	29/01/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	37.66x	13.18x	27.98x	0.53%	1,14300Cr
JOHNSON & JOHNSON	39.33x	6.61x	18.6x	1.99%	65TCr
ABBVIE INC.	37.45x	8.4x	17.37x	2.4%	51TCr
ROCHE HOLDING AG	21.46x	5.22x	12.98x	2.51%	38TCr
MERCK & CO., INC.	103.38x	5.8x	24.86x	2.4%	35TCr
NOVARTIS AG	21.99x	5.69x	13.69x	2.94%	29TCr
ASTRAZENECA PLC	22.31x	4.51x	12.87x	1.96%	26TCr
AMGEN INC.	28.42x	7.28x	13.03x	2.25%	24TCr
GILEAD SCIENCES, INC.	-45.78x	7.1x	27.53x	2.07%	20TCr
Average	29.58x	7.09x	18.77x	2.12%	44.75TCr
Weighted average by Cap.	35.27x	8.35x	20.48x	1.8%